BBVA
UBX

Banco Bilbao Vizcaya Argentaria’s Unity Biotechnology UBX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,317
Closed -$374K – 755
2020
Q2 		$374K Buy
+4,317
New +$320K 0.01% 606

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's UBX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Unity Biotechnology (UBX) in Q3 2020, closing a stake of 4,317 shares — an estimated $374K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in UBX in Q2 2020 and held it in 1 quarter. The position peaked at $374K in Q2 2020. 79 funds tracked by Wall St. Rank hold UBX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Unity Biotechnology position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 4,317 Unity Biotechnology shares in Q3 2020, an estimated $374K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Unity Biotechnology in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Unity Biotechnology position peaked at $374K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.